Log in
NASDAQ:ITCI

Intra-Cellular Therapies Earnings Date, Estimates & History

$23.98
+0.64 (+2.74 %)
(As of 10/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$22.92
Now: $23.98
$24.45
50-Day Range
$23.34
MA: $27.08
$31.86
52-Week Range
$8.51
Now: $23.98
$43.56
Volume560,859 shs
Average Volume1.31 million shs
Market Capitalization$1.61 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.65

Earnings

Intra-Cellular Therapies (NASDAQ:ITCI) Earnings Information

Intra-Cellular Therapies last posted its quarterly earnings results on August 10th, 2020. The biopharmaceutical company reported ($0.96) EPS for the quarter, missing analysts' consensus estimates of ($0.94) by $0.02. The firm had revenue of $1.91 million for the quarter, compared to analysts' expectations of $3.05 million. Intra-Cellular Therapies has generated ($2.68) earnings per share over the last year. Intra-Cellular Therapies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 3rd, 2020 based off prior year's report dates.

Intra-Cellular Therapies Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Intra-Cellular Therapies (NASDAQ:ITCI) Earnings Estimates

2020 EPS Consensus Estimate: ($3.69)
2021 EPS Consensus Estimate: ($4.00)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($0.98)($0.98)($0.98)
Q2 20202($0.97)($0.91)($0.94)
Q3 20202($0.93)($0.90)($0.92)
Q4 20202($0.88)($0.82)($0.85)
Q1 20211($1.04)($1.04)($1.04)
Q2 20211($1.04)($1.04)($1.04)
Q3 20211($1.02)($1.02)($1.02)
Q4 20211($0.90)($0.90)($0.90)

Intra-Cellular Therapies (NASDAQ ITCI) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/3/2020
(Estimated)
       
8/10/20206/30/2020($0.94)($0.96)($0.96)$3.05 million$1.91 millionTranscript
5/7/20203/31/2020($0.93)($0.73)($0.73)$1.75 million$1.08 millionListen
3/2/2020Q4 2019($0.81)($0.74)($0.74)$0.06 millionTranscript
11/5/2019Q3 2019($0.80)($0.63)($0.63)Transcript
8/7/2019Q2 2019($0.8310)($0.68)($0.68)N/A
5/8/20193/31/2019($0.90)($0.63)($0.63)N/A
2/27/2019Q4 2018($0.84)($0.75)($0.75)N/A
11/7/20189/30/2018($0.85)($0.76)($0.76)N/A
8/2/2018Q2 2018($0.76)($0.68)($0.68)N/A
5/3/2018Q1 2018($0.6630)($0.6490)($0.65)$0.10 millionN/A
3/1/2018n/a($0.50)($0.56)($0.56)$0.05 million$5.06 millionN/A
11/8/2017Q3 2017($0.53)($0.5270)($0.53)$0.06 million$0.03 millionN/A
8/9/2017Q2 2017($0.74)($0.41)($0.41)$0.03 million$0.11 millionN/A
5/10/2017Q1 2017($0.74)($0.62)($0.62)$0.02 million$0.10 millionN/A
3/1/2017Q4 2016($0.77)($0.64)($0.64)$0.10 million$0.10 millionListen
11/9/2016Q316($0.84)($0.70)($0.70)$0.04 million$4.36 millionListen
8/4/2016Q216($0.79)($0.71)($0.71)$0.02 million$0.23 millionN/A
4/28/2016Q116($0.78)($0.64)($0.64)$0.02 millionListen
2/25/2016Q415($0.84)($0.67)($0.67)$0.05 million$30.66 millionListen
11/5/2015Q315($0.66)($0.91)($0.91)$0.10 millionN/A
8/5/2015Q215($0.72)($0.61)($0.61)$40.00 million$57.40 millionN/A
4/30/2015Q1($0.68)($0.72)($0.72)N/A
3/12/2015Q4 2014($0.49)($0.52)($0.52)$0.07 millionN/A
11/3/2014Q314($0.34)($0.22)($0.22)$0.12 millionListen
8/12/2014Q214($0.24)($0.15)($0.15)$0.22 millionN/A
5/5/2014Q1 2014($0.23)($0.17)($0.17)$0.17 millionN/A
3/25/2014Q4 2013($0.41)($0.36)($0.36)$0.60 million$0.83 millionN/A
11/5/2013Q3 2013($0.23)($0.42)($0.42)$0.67 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.